Abstract 5850: Association Between Cardiac Magnetic Resonance Imaging (CMR) Parameters and Clinical Outcomes in Patients with Transthyretin Cardiac Amyloidosis on Disease Modifying Therapy
Background: Cardiac magnetic resonance imaging (CMR) is instrumental in the early diagnosis of transthyretin cardiac amyloidosis (ATTR-CA), which may be particularly beneficial for early initiation of disease modifying therapies (DMT). Prior studies have demonstrated superior outcomes in patients who had early DMT i...